Spectrascience New Company Insiders
Spectrascience New employs about 5 people. The company is managed by 7 executives with a total tenure of roughly 93 years, averaging almost 13.0 years of service per executive, having 0.71 employees per reported executive. Evaluation of Spectrascience New's management performance can provide insight into the firm performance.
| Michael Oliver CEO CEO and President COO and Director |
| Mark McWilliams Chairman Independent Chairman of the Board |
Spectrascience |
Spectrascience New Management Team Effectiveness
The company has return on total asset (ROA) of (0.9247) % which means that it has lost $0.9247 on every $100 spent on assets. This is way below average. Spectrascience New's management efficiency ratios could be used to measure how well Spectrascience New manages its routine affairs as well as how well it operates its assets and liabilities. At present, Spectrascience New's Return On Equity is projected to slightly decrease based on the last few years of reporting. At present, Spectrascience New's Total Current Assets are projected to decrease significantly based on the last few years of reporting. The current year's Debt To Assets is expected to grow to 5.10, whereas Other Assets are forecasted to decline to about 88.4 K.As of April 30, 2024, Net Loss is expected to decline to about (4.2 M)
Spectrascience New Workforce Comparison
Spectrascience New is rated fifth in number of employees category among related companies. The total workforce of Health Care industry is at this time estimated at about 242,923. Spectrascience New adds roughly 5.0 in number of employees claiming only tiny portion of equities under Health Care industry.
Spectrascience New Notable Stakeholders
A Spectrascience New stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Spectrascience New often face trade-offs trying to please all of them. Spectrascience New's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Spectrascience New's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Michael Oliver | CEO and President COO and Director | Profile | |
| Mark McWilliams | Independent Chairman of the Board | Profile | |
| Lowell Giffhorn | CFO, Principal Accounting Officer and Secretary | Profile | |
| Rand Mulford | Director | Profile | |
| Stanley Pappelbaum | Independent Director | Profile | |
| Sheldon Miller | Independent Director | Profile | |
| Duwaine Townsen | Independent Director | Profile |
About Spectrascience New Management Performance
The success or failure of an entity such as Spectrascience New often depends on how effective the management is. Spectrascience New management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Spectrascience management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Spectrascience management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (14.20) | (13.49) | |
| Return On Capital Employed | 0.23 | 0.25 | |
| Return On Assets | (3.71) | (3.52) | |
| Return On Equity | 0.38 | 0.40 |
The data published in Spectrascience New's official financial statements usually reflect Spectrascience New's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Spectrascience New. For example, before you start analyzing numbers published by Spectrascience accountants, it's critical to develop an understanding of what Spectrascience New's liquidity, profitability, and earnings quality are in the context of the Health Care Equipment & Supplies space in which it operates.
Please note, the presentation of Spectrascience New's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Spectrascience New's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Spectrascience New's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Spectrascience New. Please utilize our Beneish M Score to check the likelihood of Spectrascience New's management manipulating its earnings.
Spectrascience New Workforce Analysis
Traditionally, organizations such as Spectrascience New use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Spectrascience New within its industry.Spectrascience New Manpower Efficiency
Return on Spectrascience New Manpower
| Revenue Per Employee | 1K | |
| Revenue Per Executive | 736 | |
| Net Loss Per Employee | 893.3K | |
| Net Loss Per Executive | 638.1K |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Complementary Tools for Spectrascience Stock analysis
When running Spectrascience New's price analysis, check to measure Spectrascience New's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Spectrascience New is operating at the current time. Most of Spectrascience New's value examination focuses on studying past and present price action to predict the probability of Spectrascience New's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Spectrascience New's price. Additionally, you may evaluate how the addition of Spectrascience New to your portfolios can decrease your overall portfolio volatility.
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |
Is Spectrascience New's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Spectrascience New. If investors know Spectrascience will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Spectrascience New listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.01) | Return On Assets (0.92) |
The market value of Spectrascience New is measured differently than its book value, which is the value of Spectrascience that is recorded on the company's balance sheet. Investors also form their own opinion of Spectrascience New's value that differs from its market value or its book value, called intrinsic value, which is Spectrascience New's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Spectrascience New's market value can be influenced by many factors that don't directly affect Spectrascience New's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Spectrascience New's value and its price as these two are different measures arrived at by different means. Investors typically determine if Spectrascience New is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Spectrascience New's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.